Rubra Medicaments Ltd.
BSE: 531099 | Sector: Others |
NSE: N.A. | ISIN Code: INE396H01019 |
BSE 00:00 | 26 Dec | Rubra Medicaments Ltd |
NSE 05:30 | 01 Jan | Rubra Medicaments Ltd |
OPEN | 4.50 |
PREVIOUS CLOSE | 4.50 |
VOLUME | 999 |
52-Week high | 4.52 |
52-Week low | 2.66 |
P/E | |
Mkt Cap.(Rs cr) | 2 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Rubra Medicaments Ltd. (RUBRAMEDICAMENT) - Profit And Loss
Figures in Rs crore | 2022 | 2021 | 2020 |
Income | |||
Sales Turnover | 2.01 | 0.49 | 0.99 |
Excise Duty | 0.00 | 0.00 | 0.00 |
Net Sales | 2.01 | 0.49 | 0.99 |
Other Income | 0.00 | 0.00 | 0.03 |
Stock Adjustments | 0.00 | 0.00 | 0.00 |
Total Income | 2.01 | 0.49 | 1.02 |
Expenditure | |||
Raw Materials | 0.52 | 0.08 | 0.15 |
Power & Fuel Cost | 0.00 | 0.00 | 0.00 |
Employee Cost | 0.23 | 0.20 | 0.13 |
Other Manufacturing Expenses | 0.17 | 0.00 | 0.00 |
Selling and Administration Expenses | 0.11 | 0.07 | 0.07 |
Miscellaneous Expenses | 1.01 | 0.13 | 0.62 |
less: Pre-operative Expenses Capitalised | 0.00 | 0.00 | 0.00 |
Total Expenditure | 2.04 | 0.48 | 0.97 |
Operating Profit | -0.03 | 0.01 | 0.04 |
Interest | 0.00 | 0.00 | 0.00 |
Gross Profit | -0.03 | 0.01 | 0.04 |
Depreciation | 0.00 | 0.00 | 0.00 |
Profit Before Tax | -0.03 | 0.01 | 0.04 |
Tax | 0.01 | 0.00 | 0.01 |
Net Profit | -0.04 | 0.01 | 0.03 |
Quick Links for Rubra Medicaments:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices